Analysis of factors associated with non-acceptance of hepatitis B vaccine among low income adolescent students;Análise de fatores associados à não aceitação da vacina contra hepatite B em adolescentes escolares de baixa renda

Ciencia e Saude Coletiva

Volumn 12, Issue 5, 2007, Pages 1247-1252

  Oliveira, Michelle Dias Da Silva ^a   Paggoto, Valéria ^a   De Matos, Marcos André ^a   Kozlowski, Aline Garcia ^a   Da Silva, Nádia Rúbia ^a   Junqueira, Ana Luiza Neto ^a   Souza, Sandra Maria Brunini ^a   Martins, Regina Maria Bringel ^a   Teles, Sheila Araujo ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Adolescents; Compliance; Hepatitis B vaccine; Students

Indexed keywords

EID: 34548762964     PISSN: 14138123     EISSN: 16784561     Source Type: Journal    
DOI: 10.1590/s1413-81232007000500022     Document Type: Article

References (30)

1. EASL. EASL International Consensus Conference on hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol 2003; 38:533-540.
2. Brasil. Ministério da Saúde.Avaliação da assistência às hepatites virais no Brasil. Brasília: Ministério da Saúde; 2002.
3. Poovorawan Y, Chatchatee P, Chongsrisawat V. Epidemiology and prophylaxis of viral hepatitis: a global perspective. J Gastroenterol Hepatol 2002; 17:S155-S166.
4. McQuillan GM, Townsend TR, Fields HA, Carrol M, Leahy M, Polk BF. Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980. Am J Med 1989; 87:5S-10S.
5. Clemens S, Fonseca J, Azevedo T, Cavalcanti A, Silveira T, Castilho M, et al. Soroprevalência para hepatite A e hepatite B em quatro centros no Brasil. Rev Bras Med Trop 2000; 33:1-10.
6. Lawrence M, Goldstein MA. Hepatitis B immunizations in adolescents. J Adol Health 1995; 17:234-243.
7. Meheus A. Teenagers' lifestyle and risk of exposure to hepatitis B virus. Vaccine 2000; 18(suppl 1):S26-29.
8. Ng KP, Saw TL, Baki A, Rozainah K, Pang KW, Ramanathan M. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol (Berl) 2005; 194(3):163-8.
9. Van Damme P. Hepatitis B: vaccination programmes in Europe- an update. Vaccine 2001; 19(17-19):2375-9.
10. Brasil. Ministério da Saúde. Programa Nacional de Imunizações 30 anos. Série C. Projetos e programas e relatórios. Brasília: Ministério da Saúde; 2003.
11. James DC, Chen WW. A population-based hepatitis B vaccination coverage survey among Asian and Pacific Islander American students in Alachua County, Florida. Asian Am Pac Isl J Health 2001; 9:188-194.
12. CDC. Vaccination coverage among adolescents 1 year before institution of a seventh grade school entry vaccination requirement-San Diego, California, 1998. MMWR 2000; 49:101-12.
13. Schimidt M, Middleman AB. The importance of hepatitis B vaccination among adolescents. J Adol Health 2001; 29:217-222.
14. Linton LS, Peddecord KM, Seidman RL, Edwards C, Ross S, Gustafson K et al. Implementing a seventh grade vaccination law: school factors associated with completion of required immunizations. Prev Med 2003; 36(4):510-7.
15. Middleman AB, Robertson LM, Young C, Durant RH, Emans SJ. Predictors of time to completion of the hepatitis B vaccination series among adolescents. J Adolesc Health 1999; 25(5):323-7.
16. Cassidy WM, Mahoney FJ. A hepatitis B vaccination program targeting adolescents. J Health Adol 1995; 17:244-247.
17. Slonim AB, Roberto AJ, Downing CR, Adams IF, Fasano NJ, Davis-Satterla L, et al. Adolescents' knowledge, beliefs, and behaviors regarding hepatitis B: Insights and implications for programs targeting vaccine-preventable diseases. J Adolesc Health 2005; 36(3):178-86.
18. Moore-Caldwell SY, Werner MJ, Powell L, Greene JW. Hepatitis B vaccination in adolescents: knowledge, perceived risk, and compliance. J Adolesc Health 1997; 20(4):294-9.
19. Deeks SL, Johnson IL. Vaccine coverage during a school-based hepatitis B immunization program. Revue Canadienne de Santé Publique 1998; 89:98-101.
20. Oliveira MD, Martins RM, Matos MA, Ferreira RC, Dias MA, Carneiro MA et al. Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang vaccine in adolescents from low income families in Central Brazil. Mem Inst Oswaldo Cruz 2006; 101(3):251-6.
21. Martelli CM, Turchi M, Souto FJ, Saez-Alquezar A, Andrade AL, Zicker F. Anti-HBc testing for blood donations in areas with intermediate hepatitis B endemicity. Rev Panam Salud Publica 1999; 6(1):69-73.
22. Middleman AB. Race/ethnicity and gender disparities in the utilization of a school-based hepatitis B immunization initiative. J Adolesc Health 2004; 34(5):414-9.
23. Zuckerman J, Langer B. Hepatitis B vaccination in a school age population: a feasibility study. J Med Virol 2005; 76(1):47-54.
24. Hovell MF, Wahlgren DR, Gehrman CA. The behavioral ecological model: integrating public health and behavioral science. In: Di-Clemente RJ, Crosby RA, Kegler MC, editors. Emerging Theories in Health promotion practice and research: strategies for improving public health. San Francisco, CA: Jossey-Bass; 2002. p. 347-385.
25. Tavares BF, Beria JU, M.S L. Drug use prevalence and school performance among adolescents. Rev Saúde Publica 2001; 35:150-158.
26. De Micheli D, Formigoni ML. Drug use by Brazilian students: associations with family, psychosocial, health, demographic and behavioral characteristics. Addiction 2004; 99(5):570-8.
27. Wu LT, Schlenger WE, Galvin DM. The relationship between employment and substance use among students aged 12 to 17. J Adol Health 2003; 32:5-15.
28. Soldera M, Dalgalarrondo P, Correa Filho HR, Silva CA. Use of psychotropics drugs among students: prevalence and associated social factors. Rev Saúde Publica 2004; 38:277-283.
29. Fogarty KJ, Massoudi MS, Gallo W, Averhoff FM, Yusuf H, Fishbein D. Vaccine coverage levels after implementation of a middle school vaccination requirement, Florida, 1997-2000. Public Health Rep 2004; 119(2):163-9.
30. Brasil. Ministro do Estado da Saúde. Portaria no 597/GM de 8 de abril de 2004, 2004.